Development and Clinical Translation of immunoPET Imaging Probes for Digestive System Carcinoma
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The aim of this study is to establish and optimize the target-specific PET/CT imaging method, and its physiological and pathological distribution characteristics, on the basis of which the diagnostic efficacy of the above imaging agents in digestive system malignant tumors will be evaluated.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:
• Aged 18-75 years old and of either sex；
• Histologically confirmed diagnosis of digestive system carcinoma or suspected digestive system carcinoma by diagnostic imaging;
• Capable of giving signed informed consent, including compliance with the requirements and restrictions listed in the informed consent form (ICF) and this protocol.
Locations
Other Locations
China
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
RECRUITING
Shanghai
Contact Information
Primary
Weijun Wei, Ph.D. & M.D.
wwei@shsmu.edu.cn
15000083153
Backup
Shuxian An, Ph.D. & M.D.
anshuxian@shsmu.edu.cn
17717453484
Time Frame
Start Date: 2024-09-12
Estimated Completion Date: 2027-09
Participants
Target number of participants: 400
Treatments
Experimental: ImmunoPET imaging in patients with digestive system carcinoma
Enrolled patients will undergo a targeted-specific immunoPET/CT scanning.
Related Therapeutic Areas
Sponsors
Leads: RenJi Hospital